New customers strengthen our market positionWe leave a successful year behind us with significant new customers, strong growth in our focus market Americas, and continued commercialization of Zyntai.

Q4 2024 Earnings Call Transcript February 20, 2025 Laureate Education, Inc. beats earnings expectations. Reported EPS is $0.615, expectations were $0.42. Operator: Good day, and welcome to the Fiscal ...

Q4 2024 Earnings Call Transcript February 18, 2025 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $0.04, ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor ...

Q4 2024 Earnings Call Transcript February 19, 2025 Operator: Welcome to The Hackett Group Fourth Quarter Earnings Conference ...

Q1 2025 Earnings Call Transcript February 13, 2025 Applied Materials, Inc. beats earnings expectations. Reported EPS is $2.38 ...

Q4 2024 Earnings Call Transcript February 19, 2025 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 18, 2025 Hillman Solutions Corp. misses on earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 14, 2025 AMC Networks Inc. misses on earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 13, 2025 Hertz Global Holdings, Inc. misses on earnings expectations. Reported EPS ...

“I am pleased to share this milestone as we continue advancing toward our FDA submission and work to bring our technology to burn care institutions across the U.S.,” said Dr. J. Michael DiMaio, MD, ...

WEST ORANGE, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today announced preliminary financial results for the fourth quarter and full year of 2024. Net sales of ...